Status:

COMPLETED

Bronchoscopic Cryo-Immunotherapy of Lung Cancer

Lead Sponsor:

NYU Langone Health

Conditions:

Advanced Non-small Cell Lung Cancer

Eligibility:

All Genders

22-80 years

Phase:

EARLY_PHASE1

Brief Summary

This is a safety and feasibility study of bronchoscopic cryo-immunotherapy (BCI) of peripheral lung tumors in advanced non-small cell lung cancer for the intention of inducing anti-tumor immune respon...

Eligibility Criteria

Inclusion

  • Peripheral lung tumor on pre-procedure chest CT scan, which is known or suspected to be advanced, inoperable non-small cell lung cancer (stages IIIA/B/C and IVA/B) based on the 8th edition TNM staging guidelines
  • Pre-procedure chest CT scan with the presence of a bronchus or airway path leading directly to the peripheral lung tumor (also known as a "bronchus sign")
  • Undergoing bronchoscopy for diagnostic and/or palliative purpose unrelated to this study.
  • Documentation of non-small cell lung cancer either prior to procedure or via on-site pathology review during bronchoscopy (prior to proceeding with planned BCI)
  • Ability to provide informed consent
  • Concomitant chemotherapy, immunotherapy, and/or radiation therapy are allowed
  • ECOG performance status less than or equal to 2

Exclusion

  • Pregnancy
  • Currently on a platelet inhibitor (such as Clopidogrel) other than aspirin or NSAIDS, or on a blood thinner (such as heparin, enoxaparin, or a novel oral anticoagulant), which is unable to be held for planned bronchoscopy
  • INR \>= 1.5 (post correction)
  • Platelets =\< 100,000 (post correction)
  • Bleeding diathesis
  • Contraindication to bronchoscopy
  • Absence of tissue diagnosis of non-small cell lung cancer either prior to procedure or during on-site pathology review at time of bronchoscopy.

Key Trial Info

Start Date :

February 15 2020

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

April 9 2024

Estimated Enrollment :

21 Patients enrolled

Trial Details

Trial ID

NCT04049474

Start Date

February 15 2020

End Date

April 9 2024

Last Update

April 24 2025

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

NYU Langone Health

New York, New York, United States, 10016